A study to investigate if Bortezomib treatment response is related to NRAS/KRAS mutational status in relapsed or refractory multiple myeloma patients.
Latest Information Update: 21 Dec 2015
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Dec 2015 New trial record